Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study

NCT01089725 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

385

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Osteoarthritis
Arthritis
Pain

Interventions

BIOLOGICAL: Placebo IV
BIOLOGICAL: Placebo SC
BIOLOGICAL: Tanezumab SC
BIOLOGICAL: Placebo IV
BIOLOGICAL: Tanezumab SC
BIOLOGICAL: Placebo IV
BIOLOGICAL: Tanezumab SC
BIOLOGICAL: Placebo IV
BIOLOGICAL: Tanezumab IV
BIOLOGICAL: Placebo SC

Sponsor

Pfizer